The actual studies behind what's in our formulas — not summaries of summaries. Filter by ingredient and save the ones you want to come back to, or search the wider literature directly below, including peptide research.
Live search against PubMed — the U.S. National Library of Medicine's database, the same one researchers use. Defaults to peptide-related results; search anything.
Bloomer RJ, Canale RE, McCarthy CG, Farney TM. Oxidative Medicine and Cellular Longevity, 2012.
300 mg/day of ubiquinol (the reduced form of CoQ10) for four weeks raised plasma CoQ10 levels and was evaluated against markers of exercise-induced oxidative stress in a randomized, double-blind, crossover design.
Saihara K, et al. Biochemistry, 2017;56(50):6615–6625.
Cell-culture work showing PQQ exposure increased mitochondrial DNA content and triggered the SIRT1/PGC-1α signaling pathway — the mechanism behind PQQ's role in prompting cells to build new mitochondria rather than just maintain existing ones.
GeroScience, 2024;46(5):4671–4688.
A 12-week, double-blind, placebo-controlled trial in older adults: 250 mg/day NMN significantly raised blood NAD+ and its metabolites, and the NMN group showed a shorter 4-metre walking time and improved sleep quality versus placebo.
Schuster J, Cycelskij I, Lopresti A, Hahn A. Nature and Science of Sleep, 2025;17:2027–2040.
A 155-person randomized, placebo-controlled trial: 250 mg/day of magnesium bisglycinate produced a statistically significant, though modest, improvement in insomnia severity scores after four weeks — with larger effects in people who started with lower dietary magnesium intake.
No saved studies yet — tap the star on any card to save it here.
